ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 452,42
-0,49%
Dow Jones
42 635,20
0,25%
DAX
20 329,94
-0,10%
Brent Oil
75,99
-1,39%
Bitcoin
95 047,01
-1,91%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Vericel Corporation (VCEL) Cours

Vericel Corporation

Vericel Corporation (VCEL)

NASDAQ
59,53
1,45
(2,50%)
À la fermeture: 09 Janvier 10:00PM
Retardé de 15 minutes
59,53
-0,03
( -0,05% )
Après les heures de négociation: 10:15PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
59,53
Prix Achat
58,25
Prix Vente
60,49
Volume échangé
494 635
57,28 Fourchette du Jour 59,79
32,31 Plage de 52 semaines 61,49
Cap du marché
2,938B
Clôture Veille
58,08
Ouverture
57,865
Dernière Transaction
6
@
59.53
Dernière heure de transaction
23:26:21
Volume financier
US$ 29 221 447
VWAP
59,0768
Volume moyen (3 m)
388 591
Actions en circulation
49 358 408
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-923,41
Bénéfice par action (BPA)
-0,06
Chiffre d'affairess
197,52M
Bénéfice net
-3,18M

À propos de Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epic... Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Coml Physical, Biologcl Resh
Site Web
www.vcel.com
Siège social
Bingham Farms, Michigan, USA
Fondé
2008
Vericel Corporation est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker VCEL. Le dernier cours de clôture d'Vericel était de US$58,08. Au cours de la dernière année, les actions de Vericel ont été négociées dans une fourchette de prix de US$ 32,31 à US$ 61,49.

Vericel compte actuellement 49 358 408 actions en circulation. La capitalisation boursière d'Vericel est de US$2,87 milliard. Vericel a un ratio cours/bénéfice (ratio PE) de -923.41.

VCEL Dernières nouvelles

Plus de nouvelles

Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025

CAMBRIDGE, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that...

il y a 10 heures
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

05 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

04 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

03 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

02 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

25 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

22 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

15 Novembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

15 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
14.147.4742733345455.3959.5655.0135262857.05175911CS
41.52.5848698948858.0359.951954.1734198256.55439479CS
1217.3641.166706189242.1761.4939.7538859153.11007216CS
2612.326.042769426247.2361.4939.1236180649.80564724CS
5227.0983.508014796532.4461.4932.3140493347.37822649CS
15623.7166.192071468535.8261.4917.341564936.13795829CS
26042.44248.33235810417.0968.946.7848667134.31902732CS

VCEL - Frequently Asked Questions (FAQ)

What is the current Vericel share price?
The current share price of Vericel is US$ 59,53
How many Vericel shares are in issue?
Vericel has 49 358 408 shares in issue
What is the market cap of Vericel?
The market capitalisation of Vericel is USD 2,87B
What is the 1 year trading range for Vericel share price?
Vericel has traded in the range of US$ 32,31 to US$ 61,49 during the past year
What is the PE ratio of Vericel?
The price to earnings ratio of Vericel is -923,41
What is the cash to sales ratio of Vericel?
The cash to sales ratio of Vericel is 14,88
What is the reporting currency for Vericel?
Vericel reports financial results in USD
What is the latest annual turnover for Vericel?
The latest annual turnover of Vericel is USD 197,52M
What is the latest annual profit for Vericel?
The latest annual profit of Vericel is USD -3,18M
What is the registered address of Vericel?
The registered address for Vericel is 30600 TELEGRAPH ROAD, SUITE 2345, BINGHAM FARMS, MICHIGAN, 02139
What is the Vericel website address?
The website address for Vericel is www.vcel.com
Which industry sector does Vericel operate in?
Vericel operates in the COML PHYSICAL, BIOLOGCL RESH sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
HOLOMicroCloud Hologram Inc
US$ 2,97
(40,09%)
6,3M
STAIScanTech AI Systems Inc
US$ 2,862
(31,28%)
2,96M
LAESSEALSQ Corporation
US$ 6,35
(20,38%)
8,98M
PENGPengiun Solutions Inc
US$ 22,30
(16,57%)
207,33k
ALCEAlternus Clean Energy Inc
US$ 0,745401
(14,66%)
7,69M
XXII22nd Century Group Inc
US$ 5,60
(-30,86%)
530,09k
AVDLAvadel Pharmaceuticals PLC
US$ 7,85
(-26,57%)
785,6k
SILOSilo Pharma Inc
US$ 1,3799
(-19,30%)
1,29M
NITON2OFF Inc
US$ 1,52
(-17,39%)
694,38k
IROQIF Bancorp Inc
US$ 19,00
(-17,39%)
210
MBIOMustang Bio Inc
US$ 0,23
(3,42%)
17,17M
XTIAXTI Aerospace Inc
US$ 0,0488
(-3,37%)
16,33M
LAESSEALSQ Corporation
US$ 6,36
(20,57%)
8,99M
ALCEAlternus Clean Energy Inc
US$ 0,7411
(14,00%)
7,69M
HOLOMicroCloud Hologram Inc
US$ 2,96
(39,62%)
6,3M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
VCEL
Vericel
BOV
AZOI34
Autozone
NASDAQ
EQ
Equillium
BOV
BAUH4F
EXCELSIOR PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés